CN101843832A - Chinese medicament for treating coronary disease - Google Patents
Chinese medicament for treating coronary disease Download PDFInfo
- Publication number
- CN101843832A CN101843832A CN200910235869A CN200910235869A CN101843832A CN 101843832 A CN101843832 A CN 101843832A CN 200910235869 A CN200910235869 A CN 200910235869A CN 200910235869 A CN200910235869 A CN 200910235869A CN 101843832 A CN101843832 A CN 101843832A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese
- chinese medicine
- chinese medicament
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 13
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 206010040007 Sense of oppression Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010049119 Emotional distress Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000009429 distress Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating a coronary disease, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: glossy privet fruit, lucid ganoderma, radix pseudo-ginseng, dwarf lilyturf tuber, root of rehmannia, Chinese angelica and root of red-rooted salvia. The Chinese medicament has the effects of strengthening body resistance and banking up root, nourishing yin and tonifying blood, and activating blood and freeing vessels, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended to treat the field of Chinese medicines of coronary heart disease at present, have the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Many patients with coronary heart disease are stood the torment of feeling of oppression and pain in the chest for a long time, face the danger of myocardial infarction, and patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Fructus Ligustri Lucidi 4-30 part Ganoderma 2-15 part Radix Notoginseng 3-20 part
Radix Ophiopogonis 4-30 part Radix Rehmanniae 4-30 part Radix Angelicae Sinensis 4-30 part
Radix Salviae Miltiorrhizae 4-30 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Fructus Ligustri Lucidi, Radix Ophiopogonis, the Radix Rehmanniae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks that coronary heart disease belongs to deficiency of both QI and YIN, the resistance of the heart arteries and veins stasis of blood more, controls and works as supplementing QI and nourishing YIN, blood circulation promoting and blood stasis dispelling.Ganoderma QI invigorating the body resistance strengthening and constitution consolidating in the side, the tonification the five internal organs; The Radix Rehmanniae, the flourish arteries and veins of yin nourishing Radix Ophiopogonis; Be aided with the Fructus Ligustri Lucidi kidney-yang nourishing; Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae nourishing blood to suppress the hyperactive liver, Shu Mai invigorates blood circulation; The pseudo-ginseng blood-circulation-invigovating blood-activating analgetic.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, nourishing YIN and benefiting blood, and the merit of blood circulation and channel invigorating, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Fructus Ligustri Lucidi 80 kairine sesames 40 gram Radix Notoginseng 60 grams
Radix Ophiopogonis, the 80 gram Radix Rehmanniae, 80 gram Radix Angelicae Sinensis 60 restrained
Radix Salviae Miltiorrhizae 80 grams
Weight in accordance with regulations, with conventional water extraction process Fructus Ligustri Lucidi, Radix Ophiopogonis, the Radix Rehmanniae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted, make extractum fine powder 114 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 764 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Fructus Ligustri Lucidi 150 kairine sesames 80 gram Radix Notoginseng 120 grams
Radix Ophiopogonis, the 150 gram Radix Rehmanniae, 150 gram Radix Angelicae Sinensis 150 restrained
Radix Salviae Miltiorrhizae 150 grams
By above-mentioned same method, make 1517 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Fructus Ligustri Lucidi 300 kairine sesames 150 gram Radix Notoginseng 200 grams
Radix Ophiopogonis, the 300 gram Radix Rehmanniae, 300 gram Radix Angelicae Sinensis 300 restrained
Radix Salviae Miltiorrhizae 300 grams
By above-mentioned same method, make 2857 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
4 parts of 3 portions of Radix Notoginseng of 6 portions of Ganodermas of Fructus Ligustri Lucidi
5 parts of 6 parts of Radix Angelicae Sinensis of 6 parts of Radix Rehmanniae Radix Ophiopogonis
6 parts of Radix Salviae Miltiorrhizaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 9 portions of Radix Notoginseng of 20 portions of Ganodermas of Fructus Ligustri Lucidi
15 parts of 20 parts of Radix Angelicae Sinensis of 20 parts of Radix Rehmanniae Radix Ophiopogonis
20 parts of Radix Salviae Miltiorrhizaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science coronary heart disease, through 13 routine clinical observations.Selecting tcm diagnosis coronary heart disease is standard: have a delicate constitution, limb is soft weak, and feeling of oppression and pain in the chest is dizzy nervous, the Electrocardioscopy myocardial ischemia.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 7 examples, women's 6 examples do not have other serious disease, and the age is 42 years old-73 years old, 62.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, cardiac distresses such as feeling of oppression and pain in the chest are obviously alleviated, and the visible blood supply of cardiac muscle of electrocardiogram obviously improves.
2, effective: body constitution strengthens, and cardiac distresses such as feeling of oppression and pain in the chest are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.13 philtrums of clinical experiment, produce effects 8 people, effective 4 people, invalid 1 people, total effective rate 92.3%.
Claims (1)
1. a Chinese medicine for the treatment of coronary heart disease adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Fructus Ligustri Lucidi 4-30 part Ganoderma 2-15 part Radix Notoginseng 3-20 part
Radix Ophiopogonis 4-30 part Radix Rehmanniae 4-30 part Radix Angelicae Sinensis 4-30 part
Radix Salviae Miltiorrhizae 4-30 part
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Fructus Ligustri Lucidi, Radix Ophiopogonis, the Radix Rehmanniae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358693A CN101843832B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating coronary disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358693A CN101843832B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating coronary disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843832A true CN101843832A (en) | 2010-09-29 |
| CN101843832B CN101843832B (en) | 2011-08-10 |
Family
ID=42768770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102358693A Expired - Fee Related CN101843832B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating coronary disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843832B (en) |
-
2009
- 2009-10-28 CN CN2009102358693A patent/CN101843832B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843832B (en) | 2011-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101554470A (en) | Traditional Chinese medicine for treating tachycardia | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101843807A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101843878B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843712A (en) | Chinese medicament for treating angina | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843700A (en) | Chinese medicament for treating coronary disease | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101554441A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843705A (en) | Chinese medicament for treating lupus erythematosus | |
| CN101843866A (en) | Chinese medicament for treating diabetic feet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130710 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130710 Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180205 Address after: 409800 Chongqing city Youyang County plate brook light industrial park, 2 A Patentee after: Chongqing Wanyuan Pharmaceutical Co., Ltd. Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180312 Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd. Address before: 409800 Chongqing city Youyang County plate brook light industrial park, 2 A Patentee before: Chongqing Wanyuan Pharmaceutical Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20181028 |